Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Effects of 5-HTR2A, DRD2,and COMT Genes Polymorphisms and Drug Plasma Concentration on Antipsychotic Response to Olanzapine in Treatment of Early-onset Schizophrenia
This study has finished and is no longer accepting participants.
In Kunming
This study has finished and is no longer accepting participants.
In ShanghaiThis study evaluated the safety and effectiveness of Esketamine for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamThis study evaluated the safety and effectiveness of Esketamine for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including San Diego
This study has finished and is no longer accepting participants.
In Denver
A Multicenter Randomized Double-Blind Controlled Trial of Six-Week Transcranial Temporal Interference Stimulation（TIS） Targeting the Right Amygdala for Rapid Alleviation of Depressive Symptoms.
This study has finished and is no longer accepting participants.
Multiple locations, including GuangdongA Multicenter, Double-Blind, Flexible-Dose, 6-Month Extension Trial Comparing the Safety and Efficacy of Asenapine With Olanzapine in Subjects Who Completed the Protocol 25543 (NCT 00212836; P05817)
This study has finished and is no longer accepting participants.
Location not clearly listedA Multicenter, Double-Blind, Flexible-Dose, 6-Month Extension Trial Comparing the Safety and Efficacy of Asenapine With Olanzapine in Subjects Who Completed Protocol A7501013
This study has finished and is no longer accepting participants.
Location not clearly listedA Multicenter, Randomized, Double-blind, Fixed-dose, 6-week Trial of the Efficacy and Safety of Asenapine Compared With Placebo in Subjects With an Acute Exacerbation of Schizophrenia (Phase 3)
This study has finished and is no longer accepting participants.
Location not clearly listed7-Keto DHEA for the Treatment of PTSD
This study has finished and is no longer accepting participants.
In Bay PinesA Multi-center, Exploratory, Single-Arm, 7-week Study to Evaluate the Feasibility and Acceptability of Treatment With CT-155 in People With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Culver CityAn 8 Week Randomized Double Blind Placebo Controlled Multi-site Study Assessing Efficacy and Safety of MYDAYIS® (D-amphetamine / L-amphetamine) for Bipolar Depression
This study has finished and is no longer accepting participants.
Multiple locations, including RochesterWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.